	A machine learning-based interpretable model for predicting pancreatic cancer in chronic pancreatitis patients with focal pancreatic lesions. BMC Cancer Yi JH, Wang T, Bi YW, Xu JJ, Liu M, Chen GM, Li ZS, Wang D, Chai NL, Hu LH. PMID: 42204501 [PubMed - as supplied by publisher]
	Towards early detection of pancreatic cancer: The current status of cohort studies by the Diabetes-Pancreatic Ductal AdenoCarcinoma Working Group. Pancreatology Maitra A, Chari ST, Wu B, Van Den Eeden SK, Fisher W, Vege SS, Rinaudo JA, Feng Z, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (CPDPC). PMID: 42203568 [PubMed - as supplied by publisher]
	Preoperative Serum Total Cholesterol Predicts Adjuvant Chemotherapy Completion After Pancreaticoduodenectomy for Pancreatic Cancer. Anticancer Res Hatta K, Nishimura S, Tanaka R, Shinkawa H, Nishio K, Kinoshita M, Tauchi J, Kurihara S, Ishizawa T. PMID: 42203346 [PubMed - indexed for MEDLINE]
	Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan-Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer. Anticancer Res Maeda K, Koyama S, Kawada K, Hayashi T, Yoshioka T, Ishida T, Fukuda H, Horikawa IO, Aizawa F, Niimura T, Yagi K, Goda M, Izawa-Ishizawa Y, Abe S, Ishizawa K. PMID: 42203343 [PubMed - indexed for MEDLINE]
	Tertiary lymphoid structures (TLS): the mechanism hub and therapeutic target of neoadjuvant immunotherapy for hepatocellular carcinoma. Crit Rev Oncol Hematol Wu Q, Jin L, Cao L, Zhang C, Dou C. PMID: 42202921 [PubMed - as supplied by publisher]
	Prediction of cancer-associated thrombosis by machine learning: results from the Vienna Cancer and Thrombosis Study. ESMO Open Hoberstorfer T, Spielvogel CP, Englisch C, Vladic N, Nopp S, Moik F, Preusser M, Pabinger I, Ay C. PMID: 42202491 [PubMed - as supplied by publisher]
	Sublobar resection, stereotactic body radiotherapy, and thermal ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis. Lung Cancer Adar S, Ádám A, Balogh T, Rédei M, Fazekas KK, Paczkó M, Galdzytska N, Engh MA, Bibok A, Duray GZ, Hegyi P, Horváthy DB. PMID: 42202379 [PubMed - as supplied by publisher]
	One out of four patients with pancreatic cancer experience psychological symptoms: A systematic review and meta-analysis. PLoS One Bognár AS, Sükös DA, Patoni C, Szalai EÁ, Teutsch B, Veres DS, Hosszúfalusi N, Er, Márta K, Hegyi P. PMID: 42201880 [PubMed - indexed for MEDLINE]
	Medicare Insurance Type and Broad Genomic Profiling in Metastatic Cancer. JAMA Netw Open Chow RD, Rothen J, Long JB, Soulos PR, Wang X, Mamtani R, Ma S, Kunst N, Dinan MA, Gross CP. PMID: 42201732 [PubMed - indexed for MEDLINE]
	Correction: Robotic Liver Resection for Gallbladder Cancer: Does Common Bile Duct Resection Matter? An International Propensity-Matched Study. J Robot Surg Esposito G, Axentiev A, Ross S, Al Harakeh H, Odorizzi R, Martinie J, Memeo R, Belli A, Giulianotti PC, Troisi RI, Goh BKP, Eid MK, Romito R, Vanterpool G, Guglielmi A, Kah Heng Chiow A, Morelli L, Lopez-Lopez V, Di Benedetto F, Moraldi L, Ielpo B, Sucandy I, and IRON Study Collaborative Group. PMID: 42201447 [PubMed - in process]
	UTY (KDM6C) in Cancer: Epigenetic Regulation, Tumour Suppressor Functions, and Clinical Implications. Epigenomes Chopra C, Prasad CP, Kumar M. PMID: 42201147 [PubMed]
	Expression of ATRX, DAXX, PDX1, ARX, and somatostatin receptors in pancreatic neuroendocrine tumors: a clinicopathological study. Front Endocrinol (Lausanne) Ciobanu OA, Martin CS, Fica S, Herlea V, Tudose I, Vasilescu F, Sandra I, Barbu CG. PMID: 42199802 [PubMed - indexed for MEDLINE]
	Post-Translational Modification Networks in Ferroptosis: Orchestrating Defense, Drug Resistance, and Therapeutic Opportunities in Hepatocellular Carcinoma. J Hepatocell Carcinoma Chen J, Li L, Fang S, Zhou H. PMID: 42199338 [PubMed]
	Hyperglycaemia-Induced Metabolic Stress Promotes EMT-Driven Therapeutic Resistance in Cancer: Evidence of a Deleterious Feed-Forward Cycle. Pharmaceuticals (Basel) Zafar R, Pham TD, Vakafua L, Reed T, Seyedasli N. PMID: 42198442 [PubMed]
	Exploratory PET/CT Radiomics for Predicting Early Progression in Locally Advanced Pancreatic Cancer. Diagnostics (Basel) Fiore M, Cordelli E, Petrianni GM, D'Ercole G, Trecca P, Taralli S, La Vaccara V, Caputo D, Ippolito E, Calcagni ML, Soda P, Ramella S. PMID: 42196865 [PubMed]
	Recent Advances in Pancreatic Cancer and Biliary Tract Cancers: Biology, Biomarkers, and Evolving Systemic Therapy. Int J Mol Sci Takrori E, Abdulmajid M, Devagudi D, Sohail R, Sadiq Z, Berneau C, Shenouda A, Adelli R, Peshin S, Singal S. PMID: 42196390 [PubMed - indexed for MEDLINE]
	Do We Have Enough Evidence That Metformin Is Superior to Other Antidiabetic Drugs in Pancreatic Cancer Risk Reduction? Int J Mol Sci Szymczak-Pajor I, Drzewoski J, Wenclewska S, Rogalska A, . PMID: 42196179 [PubMed - indexed for MEDLINE]
	Trace Elements in the Pancreas: From Physiological Homeostasis to the Pathogenesis of Diabetes, Pancreatitis, and Cancer-A Review. Life (Basel) Bryli, Bryli, Sado J, Kra, Smyk M, Komar O, Woli, Forma A, Rusek K, Flieger J, Teresi, Baj J. PMID: 42195419 [PubMed]
	Evaluation of Pancreatic Lesions: Comparative Analysis of Endoscopic Ultrasonography, Computed Tomography, and Magnetic Resonance Imaging. Medicina (Kaunas) Hekimsoy S, Soylu A, Bayram M, Uzun H, Tabak O. PMID: 42195235 [PubMed - indexed for MEDLINE]
	Metastatic Patterns and Adverse Histopathologic Features in Advanced Renal Cell Carcinoma: A Five-Year Single-Center Retrospective Pathology Study. Medicina (Kaunas) Vidac A, Dema A, Barna R, Jurescu A, Natarâ, Hurmuz I, Nicolcea D, Dema V. PMID: 42195158 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 60235

Page 1 of 3012



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy